FY2025 · period end Nov '25 · from the 10-K filed Jan 27, 2026
| Metric | FY25Nov '25 | FY24Nov '24 | FY23Nov '23 | FY22Nov '22 | FY21Nov '21 |
|---|---|---|---|---|---|
| Revenue | $26.62B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 10-Q | 0000815097-26-000096 | May 31, 2026 | Jun 26, 2026 | Jun 26, 2026 14:13 UTC | EDGAR |
| 8-K | 0000815097-26-000086 | Jun 23, 2026 | Jun 23, 2026 | Jun 23, 2026 13:16 UTC | EDGAR |
| 8-K | 0001104659-26-057200 | May 7, 2026 | May 7, 2026 | May 7, 2026 20:32 UTC | EDGAR |
| 8-K | 0000815097-26-000043 | Apr 17, 2026 | Apr 20, 2026 | Apr 20, 2026 13:31 UTC | EDGAR |
| 8-K | 0000815097-26-000034 | Mar 27, 2026 | Mar 27, 2026 | Mar 27, 2026 13:18 UTC | EDGAR |
| 10-Q | 0000815097-26-000037 | Feb 28, 2026 | Mar 27, 2026 | Mar 27, 2026 15:12 UTC | EDGAR |
| 8-K | 0000950142-26-000454 | Feb 20, 2026 | Feb 20, 2026 | Feb 20, 2026 21:22 UTC | EDGAR |
| 8-K | 0000950142-26-000354 | Feb 12, 2026 | Feb 12, 2026 | Feb 12, 2026 21:45 UTC | EDGAR |
Direct links to SEC EDGAR. CCL has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q1 2014
Major restatementwas-$14M
Revised down in a 10-Q.
Net Income (Loss) Attributable to Parent·Q1 2014
Major restatementwas-$15M
Revised down in a 10-Q.
Net Income (Loss) Attributable to Parent·Q2 2014
Notable restatementwas$106M
Revised down in a 10-Q. Any P/E built on the original was 8.2% too low.
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest·Q2 2014
Notable restatementwas$107M
Revised down in a 10-Q.
Operating Income (Loss)·Q1 2014
Notable restatementwas$72M
Revised down in a 10-Q.
Operating Income (Loss)·Q2 2014
Notable restatementwas$155M
Revised down in a 10-Q.
CCL is not the only one.
See every restatement we've found across the market — or get an alert the next time CCL revises a number.
Restatements are detected by comparing every vintage of a fact across all of Carnival Corp Ltd.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows CCL's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling Carnival Corp Ltd. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on CCL yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on CCL and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $21.59B |
| $12.17B |
| $1.91B |
| Gross Profit | — | $9.38B | $7.28B | $0.41B | negative: -$2.75B |
|---|
| Operating Income | $4.48B | $3.57B | $1.96B | negative: -$4.38B | negative: -$7.09B |
|---|
| Net Income | $2.76B | $1.92B | negative: -$0.07B | negative: -$6.09B | negative: -$9.50B |
|---|
| EPS (Diluted) | $2.02 | $1.44 | negative: -$0.06 | negative: -$5.16 | negative: -$8.46 |
|---|
| Metric | FY25Nov '25 | FY24Nov '24 | FY23Nov '23 | FY22Nov '22 | FY21Nov '21 |
|---|---|---|---|---|---|
| Total Assets | $51.69B | $49.06B | $49.12B | $51.70B | $53.34B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $12.27B | $9.25B | $6.88B | $7.07B | $12.14B |
| Cash & Equivalents | $1.93B | $1.23B | $2.42B | $6.04B | $8.98B |
| Total Debt | $26.64B | $27.48B | $30.57B | $34.55B | $33.23B |
| Metric | FY25Nov '25 | FY24Nov '24 | FY23Nov '23 | FY22Nov '22 | FY21Nov '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6.22B | $5.92B | $4.28B | negative: -$1.67B | negative: -$4.11B |
| Capital Expenditures | $3.61B | $4.63B | $3.28B | $4.94B | $3.61B |
| Free Cash Flow | $2.61B | $1.30B | $1.00B | negative: -$6.61B | negative: -$7.72B |
| Metric | FY25Nov '25 | FY24Nov '24 | FY23Nov '23 | FY22Nov '22 | FY21Nov '21 |
|---|---|---|---|---|---|
| Gross Margin | — | 37.5% | 33.7% | 3.4% | negative: -144.0% |
| Operating Margin | 0.2% | 0.1% | negative: -0.1% | negative: -0.4% | negative: -3.7% |
| Net Margin | 0.1% | 0.1% | negative: -0.0% | negative: -0.5% | negative: -5.0% |
| Return on Equity | 25.6% | 23.8% | negative: -1.1% | negative: -63.4% | negative: -58.1% |
| Return on Assets | 5.5% | 3.9% | negative: -0.1% | negative: -11.6% | negative: -17.8% |
| Debt / Equity | 2.17× | 2.97× | 4.44× | 4.89× | 2.74× |
